Gilead's potential coronavirus treatment gets FDA's orphan drug label
The announcement comes days after U.S. President Donald Trump called on the FDA to streamline its approval process for treatments such as remdesivir, which is currently being tested in clinical trials, with results expected as early as next month.
from Hindustan Times - world https://ift.tt/2JebX2i
from Hindustan Times - world https://ift.tt/2JebX2i
Comments
Post a Comment